Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sal Lee Goh
Observed names:
S. Goh,
Sal Goh
Institution:
QIMR Berghofer Medical Research Institute
Observed institutions:
Translational Research Institute,
The University of Queensland,
National University of Singapore,
QIMR Berghofer Medical Research Institute,
Mater Research
ORCID:
0000-0002-0727-7200
Observed ORCID:
0000-0002-0727-7200
OpenAlex ID:
A5060309462
Systemic Delivery of Fusogenic Membrane Glycoprotein-expressing Neural Stem Cells to Selectively Kill Tumor Cells
2013
·
Detu Zhu
, Dang Hoang Lam
, et al.
·
Molecular Therapy
·
38
Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
·
Molecular Cancer Therapeutics
·
11
PDF
Therapeutic Blockade of Macrophage Colony Stimulating Factor (CSF-1) Delays AML Progression in Mice In Vivo
2016
·
Sal Lee Goh
, Jean-Pierre Levesque
, et al.
·
Blood
·
1
Abstract PS5-08-04: A phase 1b, multi-centre, open-label, randomized study to evaluate the safety, tolerability, and clinical activity of combining paxalisib with olaparib or pembrolizumab/chemotherapy in patients with advanced breast cancer
2026
·
M. Nottage
, M. Melino
, et al.
·
Clinical Cancer Research
Abstract PS2-10-02: Liquid Biopsy Tracking of PI3K-mTOR Residual Disease Signatures in Metastatic Breast Cancer
2026
·
M. Melino
, W. Tu
, et al.
·
Clinical Cancer Research
Supplementary Results from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
Supplementary Figure 5 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Figure 1 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Figure 2 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Figure 4 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Data from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
Supplementary Table S3 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Methods from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
Supplementary Figure 3 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Figure 6 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Figure 7 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Table S2 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Supplementary Table S1 from Depleting the Action of EZH2 through PI3K–mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer
2025
·
Michelle Melino
, Wen Juan Tu
, et al.
PDF
Role of bone marrow niches in the regulation of normal and malignant haematopoietic stem cells
2019
·
Sal Goh
·
The University of Queensland
Therapeutic blockade of macrophage colony stimulating factor (CSF-1) delays leukaemia progression of AML in mice in vivo
2016
·
Sal Lee Goh
, Jean- Pierre Levesque
, et al.
·
Experimental Hematology
Cancer Gene Therapy Potential of Neural Stem Cells Derived from Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
2013
·
Jing Yang
, Sal Lee Goh
, et al.
·
Stem cells and cancer stem cells
Show more works
View as search
Works count:
21
Citation count:
50
H-index:
2
I10-index:
2
Year
Topic
Type